SYRE
Spyre Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
SYRE fundamentals
Spyre Therapeutics (SYRE) expects to report earnings on Aug 6, 2025, with estimated revenue of -- (YoY 0.00%), and EPS at -0.71 (YoY +17.44%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
-0.71
+17.44%
Report date
Aug 6, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Spyre Therapeutics (SYRE) key financial stats and ratios, covering profitability, financial health, and leverage.
Spyre Therapeutics (SYRE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Spyre Therapeutics (SYRE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Spyre Therapeutics (SYRE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Spyre Therapeutics (SYRE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Spyre Therapeutics (SYRE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Spyre Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Spyre Therapeutics’s revenue and profit?What does Spyre Therapeutics do and what are its main business segments?What were the key takeaways from Spyre Therapeutics’s earnings call?What is the market’s earnings forecast for Spyre Therapeutics next quarter?What is the revenue and EPS growth rate for Spyre Therapeutics year over year?What guidance did Spyre Therapeutics’s management provide for the next earnings period? What is Spyre Therapeutics’s gross profit margin?